BRCAness in prostate cancer.
作者信息
Bednarz-Knoll Natalia, Eltze Elke, Semjonow Axel, Brandt Burkhard
机构信息
Natalia Bednarz-Knoll: Laboratory of Cell Biology, Department of Medical Biotechnology, Medical University of Gdańsk, Gdańsk, Poland.
出版信息
Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818.
Abstract
摘要
相似文献
1
BRCAness in prostate cancer.前列腺癌中的BRCA样状态
Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818.
2
BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapy.BRCA状态可预测三阴性乳腺癌新辅助化疗期间对含紫杉烷方案的耐药性。
Clin Breast Cancer. 2015 Feb;15(1):80-5. doi: 10.1016/j.clbc.2014.08.003. Epub 2014 Sep 28.
3
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.新辅助化疗治疗的三阴性乳腺癌患者的BRCAness与预后
PLoS One. 2016 Dec 9;11(12):e0165721. doi: 10.1371/journal.pone.0165721. eCollection 2016.
4
BRCAness is beneficial for indicating triple negative breast cancer patients resistant to taxane.BRCAness有助于指示对紫杉烷耐药的三阴性乳腺癌患者。
Eur J Surg Oncol. 2016 Jul;42(7):999-1001. doi: 10.1016/j.ejso.2016.02.246. Epub 2016 Mar 2.
5
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.遗传性和散发性乳腺癌中免疫组织化学、拷贝数畸变和表观遗传紊乱与BRCAness模式的关系。
Fam Cancer. 2016 Apr;15(2):193-200. doi: 10.1007/s10689-015-9864-2.
6
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.BRCAness作为三阴性乳腺癌患者预后及蒽环类辅助化疗反应的预测生物标志物
PLoS One. 2016 Dec 15;11(12):e0167016. doi: 10.1371/journal.pone.0167016. eCollection 2016.
7
BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness.BRCA1/2基因阴性的遗传性三阴性乳腺癌表现出BRCA基因缺陷特征。
Int J Cancer. 2017 Apr 1;140(7):1545-1550. doi: 10.1002/ijc.30570. Epub 2017 Jan 24.
8
Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer.BRCA1 蛋白表达缺失作为 BRCAness 表型的标志物与散发性卵巢癌完全切除术后的总生存预后良好相关。
Int J Gynecol Cancer. 2011 Nov;21(8):1399-406. doi: 10.1097/IGC.0b013e318227c990.
9
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.依托泊苷对不同乳腺癌细胞系中 BRCA1 表达的影响。
Drugs R D. 2017 Dec;17(4):569-583. doi: 10.1007/s40268-017-0208-6.
10
-Mutated Estrogen Receptor-Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency.- 突变型雌激素受体阳性乳腺癌具有 BRCA 特征，提示对靶向同源重组缺陷的药物敏感。
Clin Cancer Res. 2017 Mar 1;23(5):1236-1241. doi: 10.1158/1078-0432.CCR-16-0198. Epub 2016 Sep 12.
引用本文的文献
1
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.BRCA1和BRCA2甲基化作为癌症的预后和预测生物标志物：在精准医学时代液体活检中的应用
Clin Epigenetics. 2024 Dec 6;16(1):178. doi: 10.1186/s13148-024-01787-8.
2
Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment.在富含胶原蛋白的微环境中，染色质桥解聚过程中Emerin的定位错误可驱动前列腺癌细胞的侵袭性。
Exp Mol Med. 2024 Sep;56(9):2016-2032. doi: 10.1038/s12276-024-01308-w. Epub 2024 Sep 2.
3
DNA repair deficiency as circulating biomarker in prostate cancer.DNA修复缺陷作为前列腺癌的循环生物标志物
Front Oncol. 2023 Jan 30;13:1115241. doi: 10.3389/fonc.2023.1115241. eCollection 2023.
4
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations.BRCA 基因突变与前列腺癌：评估、影响及治疗策略考量。
Int J Mol Sci. 2021 Nov 23;22(23):12628. doi: 10.3390/ijms222312628.
5
Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.循环肿瘤 DNA 检测在前列腺癌同源重组修复基因中的应用：从实验室到临床。
Int J Mol Sci. 2021 May 24;22(11):5522. doi: 10.3390/ijms22115522.
6
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer.三阴性乳腺癌对PARP抑制剂耐药的新视角
Front Oncol. 2020 Nov 25;10:578095. doi: 10.3389/fonc.2020.578095. eCollection 2020.
本文引用的文献
1
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.BRCA1 基因的体细胞异常与前列腺癌中的 ALDH1、EGFR 和肿瘤进展有关。
Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.
2
Minimal functional driver gene heterogeneity among untreated metastases.未治疗转移灶中功能性驱动基因的最小异质性。
Science. 2018 Sep 7;361(6406):1033-1037. doi: 10.1126/science.aat7171.
3
Relevance of poly (ADP-ribose) polymerase inhibitors in prostate cancer.聚（ADP - 核糖）聚合酶抑制剂在前列腺癌中的相关性。
Curr Opin Support Palliat Care. 2018 Sep;12(3):339-343. doi: 10.1097/SPC.0000000000000358.
4
Summary statement on screening for prostate cancer in Europe.关于欧洲前列腺癌筛查的总结声明。
Int J Cancer. 2018 Feb 15;142(4):741-746. doi: 10.1002/ijc.31102. Epub 2017 Oct 25.
5
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.使用多基因风险评分预测男性BRCA1和BRCA2突变携带者的乳腺癌和前列腺癌风险
J Clin Oncol. 2017 Jul 10;35(20):2240-2250. doi: 10.1200/JCO.2016.69.4935. Epub 2017 Apr 27.
6
BRCAness revisited.BRCAness 再探。
Nat Rev Cancer. 2016 Feb;16(2):110-20. doi: 10.1038/nrc.2015.21. Epub 2016 Jan 18.
7
Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.探索前列腺癌基因组发现，在根治性前列腺切除术后前列腺特异抗原复发的患者中，PTEN、FAS和PAPSS2同时缺失。
Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856.
8
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.BRCA1 缺失导致乳腺上皮细胞中表皮生长因子受体表达增加，表皮生长因子受体抑制可预防 BRCA1 突变小鼠中雌激素受体阴性癌症。
Breast Cancer Res. 2011 Mar 11;13(2):R30. doi: 10.1186/bcr2850.
9
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.BRCA1 缺失预先存在于前列腺癌的小亚群中，与晚期疾病以及淋巴结和外周血转移有关。
Clin Cancer Res. 2010 Jul 1;16(13):3340-8. doi: 10.1158/1078-0432.CCR-10-0150. Epub 2010 Jun 30.
10
Getting to the root of BRCA1-deficient breast cancer.探寻BRCA1基因缺陷型乳腺癌的根源。
Cell Stem Cell. 2009 Sep 4;5(3):229-30. doi: 10.1016/j.stem.2009.08.007.
Zotero 插件